Ma T - Search Results

1

Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer's disease model mice.

Beckelman BC, Yang W, Kasica NP, Zimmermann HR, Zhou X, Keene CD, Ryazanov AG, Ma T. Beckelman BC, et al. Among authors: ma t. J Clin Invest. 2019 Feb 1;129(2):820-833. doi: 10.1172/JCI122954. Epub 2019 Jan 22. J Clin Invest. 2019. PMID: 30667373 Free PMC article.

2

Impaired Eukaryotic Elongation Factor 1A Expression in Alzheimer's Disease.

Beckelman BC, Zhou X, Keene CD, Ma T. Beckelman BC, et al. Among authors: ma t. Neurodegener Dis. 2016;16(1-2):39-43. doi: 10.1159/000438925. Epub 2015 Nov 10. Neurodegener Dis. 2016. PMID: 26551858 Free PMC article.

3

Repression of the eIF2α kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease.

Yang W, Zhou X, Zimmermann HR, Cavener DR, Klann E, Ma T. Yang W, et al. Among authors: ma t. Neurobiol Aging. 2016 May;41:19-24. doi: 10.1016/j.neurobiolaging.2016.02.005. Epub 2016 Feb 13. Neurobiol Aging. 2016. PMID: 27103515 Free PMC article.

4

Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease.

Beckelman BC, Day S, Zhou X, Donohue M, Gouras GK, Klann E, Keene CD, Ma T. Beckelman BC, et al. Among authors: ma t. J Alzheimers Dis. 2016 Sep 6;54(2):669-78. doi: 10.3233/JAD-160036. J Alzheimers Dis. 2016. PMID: 27567813 Free PMC article.

5

Glucagon-like peptide-1 cleavage product GLP-1 (9-36) amide enhances hippocampal long-term synaptic plasticity in correlation with suppression of Kv4.2 expression and eEF2 phosphorylation.

Day SM, Yang W, Ewin S, Zhou X, Ma T. Day SM, et al. Among authors: ma t. Hippocampus. 2017 Dec;27(12):1264-1274. doi: 10.1002/hipo.22795. Epub 2017 Aug 30. Hippocampus. 2017. PMID: 28833775 Free PMC article.

6

Genetic removal of eIF2α kinase PERK in mice enables hippocampal L-LTP independent of mTORC1 activity.

Zimmermann HR, Yang W, Beckelman BC, Kasica NP, Zhou X, Galli LD, Ryazanov AG, Ma T. Zimmermann HR, et al. Among authors: ma t. J Neurochem. 2018 Jul;146(2):133-144. doi: 10.1111/jnc.14306. J Neurochem. 2018. PMID: 29337352 Free PMC article.

7

Therapeutic Potential of AMP-Activated Protein Kinase in Alzheimer's Disease.

Wang X, Zimmermann HR, Ma T. Wang X, et al. Among authors: ma t. J Alzheimers Dis. 2019;68(1):33-38. doi: 10.3233/JAD-181043. J Alzheimers Dis. 2019. PMID: 30776001 Free PMC article. Review.

8

Glucagon-Like Peptide-1 Cleavage Product Improves Cognitive Function in a Mouse Model of Down Syndrome.

Day SM, Yang W, Wang X, Stern JE, Zhou X, Macauley SL, Ma T. Day SM, et al. Among authors: ma t. eNeuro. 2019 May 15;6(2):ENEURO.0031-19.2019. doi: 10.1523/ENEURO.0031-19.2019. Print 2019 Mar/Apr. eNeuro. 2019. PMID: 31040160 Free PMC article.

9

Memory Decline and Behavioral Inflexibility in Aged Mice Are Correlated With Dysregulation of Protein Synthesis Capacity.

Yang W, Zhou X, Ma T. Yang W, et al. Among authors: ma t. Front Aging Neurosci. 2019 Sep 4;11:246. doi: 10.3389/fnagi.2019.00246. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31551760 Free PMC article.

10

Brain-specific repression of AMPKα1 alleviates pathophysiology in Alzheimer's model mice.

Zimmermann HR, Yang W, Kasica NP, Zhou X, Wang X, Beckelman BC, Lee J, Furdui CM, Keene CD, Ma T. Zimmermann HR, et al. Among authors: ma t. J Clin Invest. 2020 Jul 1;130(7):3511-3527. doi: 10.1172/JCI133982. J Clin Invest. 2020. PMID: 32213711 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,351 results

Search Page

Filters